Adaptyx Biosciences
Developer of a continuous biochemical monitoring platform that combines programmable molecular recognition elements, a minimally-invasive wearable patch for interstitial fluid access, and machine learning-driven analytics to provide continuous molecular data streams for clinical decision support. Platform work includes high-throughput engineering of molecular switches, multiplexed sensing of metabolites, drugs, electrolytes and proteins, and development-stage human feasibility testing.
Industries
N/A
Nr. of Employees
small (1-50)
Patents
Products
Wearable continuous biomarker patch (development-stage)
A minimally-invasive patch device that accesses interstitial fluid and reads signals from arrays of programmable molecular switches to produce continuous biochemical data streams.
Wearable continuous biomarker patch (development-stage)
A minimally-invasive patch device that accesses interstitial fluid and reads signals from arrays of programmable molecular switches to produce continuous biochemical data streams.
Services
Contract or partnership capability to design, screen, and optimize programmable molecular switches using automated and parallelized workflows, producing standardized datasets for design iteration.
Analytics layer that ingests continuous multiplexed biomarker data to detect trends, generate clinician dashboards, and provide AI-assisted insights.
Contract or partnership capability to design, screen, and optimize programmable molecular switches using automated and parallelized workflows, producing standardized datasets for design iteration.
Analytics layer that ingests continuous multiplexed biomarker data to detect trends, generate clinician dashboards, and provide AI-assisted insights.
Expertise Areas
- Continuous biochemical monitoring
- Molecular switch and aptamer-based sensor development
- High-throughput biomolecular engineering
- Machine learning for assay design and optimization
Key Technologies
- Programmable molecular switches (synthetic DNA architectures)
- Aptamer-based biosensing
- High-throughput/massively-parallel screening
- Automated biomolecular engineering
News & Updates
Site references multiple peer-reviewed publications (2009–2024) demonstrating aptamer-based continuous monitoring, high-throughput selection methods, closed-loop dosing in animal models, and methods for optimizing aptamer performance in physiological conditions.
The company reports that human feasibility studies for the continuous monitoring platform are in progress.
Platform development is built on Stanford-led research with multiple publications and patent families licensed to the company.
Site references multiple peer-reviewed publications (2009–2024) demonstrating aptamer-based continuous monitoring, high-throughput selection methods, closed-loop dosing in animal models, and methods for optimizing aptamer performance in physiological conditions.
The company reports that human feasibility studies for the continuous monitoring platform are in progress.
Platform development is built on Stanford-led research with multiple publications and patent families licensed to the company.